Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Bronchodilators
1.2.3 PDE-4 Inhibitors
1.2.4 Steroids
1.2.5 Combination Therapies
1.2.6 Others
1.3 Market by Application
1.3.1 Global COPD Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global COPD Drugs Market Perspective (2018-2033)
2.2 COPD Drugs Growth Trends by Region
2.2.1 Global COPD Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 COPD Drugs Historic Market Size by Region (2018-2023)
2.2.3 COPD Drugs Forecasted Market Size by Region (2024-2033)
2.3 COPD Drugs Market Dynamics
2.3.1 COPD Drugs Industry Trends
2.3.2 COPD Drugs Market Drivers
2.3.3 COPD Drugs Market Challenges
2.3.4 COPD Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COPD Drugs Players by Revenue
3.1.1 Global Top COPD Drugs Players by Revenue (2018-2023)
3.1.2 Global COPD Drugs Revenue Market Share by Players (2018-2023)
3.2 Global COPD Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COPD Drugs Revenue
3.4 Global COPD Drugs Market Concentration Ratio
3.4.1 Global COPD Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Drugs Revenue in 2022
3.5 COPD Drugs Key Players Head office and Area Served
3.6 Key Players COPD Drugs Product Solution and Service
3.7 Date of Enter into COPD Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COPD Drugs Breakdown Data by Type
4.1 Global COPD Drugs Historic Market Size by Type (2018-2023)
4.2 Global COPD Drugs Forecasted Market Size by Type (2024-2033)
5 COPD Drugs Breakdown Data by Application
5.1 Global COPD Drugs Historic Market Size by Application (2018-2023)
5.2 Global COPD Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America COPD Drugs Market Size (2018-2033)
6.2 North America COPD Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America COPD Drugs Market Size by Country (2018-2023)
6.4 North America COPD Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe COPD Drugs Market Size (2018-2033)
7.2 Europe COPD Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe COPD Drugs Market Size by Country (2018-2023)
7.4 Europe COPD Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific COPD Drugs Market Size (2018-2033)
8.2 Asia-Pacific COPD Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific COPD Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific COPD Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America COPD Drugs Market Size (2018-2033)
9.2 Latin America COPD Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America COPD Drugs Market Size by Country (2018-2023)
9.4 Latin America COPD Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COPD Drugs Market Size (2018-2033)
10.2 Middle East & Africa COPD Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa COPD Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa COPD Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer COPD Drugs Introduction
11.1.4 Pfizer Revenue in COPD Drugs Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis COPD Drugs Introduction
11.2.4 Novartis Revenue in COPD Drugs Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline COPD Drugs Introduction
11.3.4 GlaxoSmithKline Revenue in COPD Drugs Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck COPD Drugs Introduction
11.4.4 Merck Revenue in COPD Drugs Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories COPD Drugs Introduction
11.5.4 Abbott Laboratories Revenue in COPD Drugs Business (2018-2023)
11.5.5 Abbott Laboratories Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim COPD Drugs Introduction
11.6.4 Boehringer Ingelheim Revenue in COPD Drugs Business (2018-2023)
11.6.5 Boehringer Ingelheim Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca COPD Drugs Introduction
11.7.4 AstraZeneca Revenue in COPD Drugs Business (2018-2023)
11.7.5 AstraZeneca Recent Development
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Detail
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG COPD Drugs Introduction
11.8.4 Roche Holding AG Revenue in COPD Drugs Business (2018-2023)
11.8.5 Roche Holding AG Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Detail
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries COPD Drugs Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2018-2023)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Vectura Group
11.10.1 Vectura Group Company Detail
11.10.2 Vectura Group Business Overview
11.10.3 Vectura Group COPD Drugs Introduction
11.10.4 Vectura Group Revenue in COPD Drugs Business (2018-2023)
11.10.5 Vectura Group Recent Development
11.11 Mylan NV
11.11.1 Mylan NV Company Detail
11.11.2 Mylan NV Business Overview
11.11.3 Mylan NV COPD Drugs Introduction
11.11.4 Mylan NV Revenue in COPD Drugs Business (2018-2023)
11.11.5 Mylan NV Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global COPD Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Bronchodilators
Table 3. Key Players of PDE-4 Inhibitors
Table 4. Key Players of Steroids
Table 5. Key Players of Combination Therapies
Table 6. Key Players of Others
Table 7. Global COPD Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global COPD Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global COPD Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global COPD Drugs Market Share by Region (2018-2023)
Table 11. Global COPD Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global COPD Drugs Market Share by Region (2024-2033)
Table 13. COPD Drugs Market Trends
Table 14. COPD Drugs Market Drivers
Table 15. COPD Drugs Market Challenges
Table 16. COPD Drugs Market Restraints
Table 17. Global COPD Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global COPD Drugs Market Share by Players (2018-2023)
Table 19. Global Top COPD Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Drugs as of 2022)
Table 20. Ranking of Global Top COPD Drugs Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by COPD Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players COPD Drugs Product Solution and Service
Table 24. Date of Enter into COPD Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global COPD Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global COPD Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global COPD Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global COPD Drugs Revenue Market Share by Type (2024-2033)
Table 30. Global COPD Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global COPD Drugs Revenue Market Share by Application (2018-2023)
Table 32. Global COPD Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global COPD Drugs Revenue Market Share by Application (2024-2033)
Table 34. North America COPD Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America COPD Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America COPD Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe COPD Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe COPD Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe COPD Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific COPD Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific COPD Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific COPD Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America COPD Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America COPD Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America COPD Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa COPD Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa COPD Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa COPD Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer COPD Drugs Product
Table 52. Pfizer Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis COPD Drugs Product
Table 57. Novartis Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. GlaxoSmithKline Company Detail
Table 60. GlaxoSmithKline Business Overview
Table 61. GlaxoSmithKline COPD Drugs Product
Table 62. GlaxoSmithKline Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 63. GlaxoSmithKline Recent Development
Table 64. Merck Company Detail
Table 65. Merck Business Overview
Table 66. Merck COPD Drugs Product
Table 67. Merck Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Abbott Laboratories Company Detail
Table 70. Abbott Laboratories Business Overview
Table 71. Abbott Laboratories COPD Drugs Product
Table 72. Abbott Laboratories Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 73. Abbott Laboratories Recent Development
Table 74. Boehringer Ingelheim Company Detail
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim COPD Drugs Product
Table 77. Boehringer Ingelheim Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. AstraZeneca Company Detail
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca COPD Drugs Product
Table 82. AstraZeneca Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Roche Holding AG Company Detail
Table 85. Roche Holding AG Business Overview
Table 86. Roche Holding AG COPD Drugs Product
Table 87. Roche Holding AG Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 88. Roche Holding AG Recent Development
Table 89. Teva Pharmaceutical Industries Company Detail
Table 90. Teva Pharmaceutical Industries Business Overview
Table 91. Teva Pharmaceutical Industries COPD Drugs Product
Table 92. Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 93. Teva Pharmaceutical Industries Recent Development
Table 94. Vectura Group Company Detail
Table 95. Vectura Group Business Overview
Table 96. Vectura Group COPD Drugs Product
Table 97. Vectura Group Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 98. Vectura Group Recent Development
Table 99. Mylan NV Company Detail
Table 100. Mylan NV Business Overview
Table 101. Mylan NV COPD Drugs Product
Table 102. Mylan NV Revenue in COPD Drugs Business (2018-2023) & (US$ Million)
Table 103. Mylan NV Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COPD Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global COPD Drugs Market Share by Type: 2022 VS 2033
Figure 3. Bronchodilators Features
Figure 4. PDE-4 Inhibitors Features
Figure 5. Steroids Features
Figure 6. Combination Therapies Features
Figure 7. Others Features
Figure 8. Global COPD Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global COPD Drugs Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. COPD Drugs Report Years Considered
Figure 14. Global COPD Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global COPD Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global COPD Drugs Market Share by Region: 2022 VS 2033
Figure 17. Global COPD Drugs Market Share by Players in 2022
Figure 18. Global Top COPD Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Drugs as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by COPD Drugs Revenue in 2022
Figure 20. North America COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America COPD Drugs Market Share by Country (2018-2033)
Figure 22. United States COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe COPD Drugs Market Share by Country (2018-2033)
Figure 26. Germany COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific COPD Drugs Market Share by Region (2018-2033)
Figure 34. China COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America COPD Drugs Market Share by Country (2018-2033)
Figure 42. Mexico COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa COPD Drugs Market Share by Country (2018-2033)
Figure 46. Turkey COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia COPD Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 50. GlaxoSmithKline Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 52. Abbott Laboratories Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 54. AstraZeneca Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 55. Roche Holding AG Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 56. Teva Pharmaceutical Industries Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 57. Vectura Group Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 58. Mylan NV Revenue Growth Rate in COPD Drugs Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed